KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Receivables - Net: 2010-2024

Historic Receivables - Net for Novavax (NVAX) over the last 13 years, with Dec 2024 value amounting to $116.0 million.

  • Novavax's Receivables - Net fell 59.23% to $41.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.8 million, marking a year-over-year decrease of 59.23%. This contributed to the annual value of $116.0 million for FY2024, which is 61.97% down from last year.
  • Per Novavax's latest filing, its Receivables - Net stood at $116.0 million for FY2024, which was down 61.97% from $304.9 million recorded in FY2023.
  • In the past 5 years, Novavax's Receivables - Net registered a high of $455.0 million during FY2021, and its lowest value of $96.2 million during FY2022.
  • Moreover, its 3-year median value for Receivables - Net was $116.0 million (2024), whereas its average is $172.4 million.
  • Per our database at Business Quant, Novavax's Receivables - Net skyrocketed by 3,393.49% in 2020 and then plummeted by 78.85% in 2022.
  • Novavax's Receivables - Net (Yearly) stood at $262.0 million in 2020, then surged by 73.65% to $455.0 million in 2021, then tumbled by 78.85% to $96.2 million in 2022, then spiked by 216.93% to $304.9 million in 2023, then plummeted by 61.97% to $116.0 million in 2024.